169331 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
USE OF PROCALCITONIN (PCT) IN RISK STRATIFICATION AND PROGNOSIS OF PATIENTS WITH A PRIMARY, NON-INFECTIOUS DISEASE
#5102ASSAYS FOR DIAGNOSING AND EVALUATING TREATMENT OPTIONS FOR POMPE DISEASE
#5103Method for predicting the response to HER2-directed therapy
#5104METHOD FOR PREDICTING A NEED FOR RENAL REPLACEMENT THERAPY (RRT)
#5105MARKER FOR DETECTING IL-17-PRODUCING HELPER T CELL, AND METHOD FOR DETECTING IL-17-PRODUCING HELPER T CELL
#5106Diagnostics and Therapeutics for Diseases Associated with G-Protein Coupled Receptor AdipoR2 (AdipoR2)
#5107Anti-alpha2 integrin antibodies and their uses
#5108Methods to diagnose and immunize against the virus causing human Merkel cell carcinoma
#5109THERAPEUTIC AGENT AND TEST AGENT FOR DISEASE WITH MYOCARDIAL NECROSIS
#5110IN VITRO DIAGNOSIS/PROGNOSIS METHOD AND KIT FOR ASSESSMENT OF TOLERANCE IN LIVER TRANSPLANTATION
#5111D-dimer, troponin, and NT-proBNP for pulmonary embolism
#5112Biomarker for diagnosis of liver disease
#5113Prognosis Biomarker for Evaluating the Cure Level of Stroke Patient and a Method thereof
#5114Methods Of Detecting Or Monitoring Activity Of An Inflammatory Condition Or Neurodegenerative Condition
#5115Assay for diagnosis of cardiac myocyte damage
#5116Assay for cardiac troponin-T (cTnT)
#5117Mammalian receptor protein DCRS5; methods of treatment
#5118Use of a neuregulin to treat peripheral nerve injury
#5119Biomarkers and assays for myocardial infarction
#5120Methods for assessing modified LDL immune complexes in subjects having or at risk of coronary artery disease
#5121Marker Detection for Characterizing the Risk of Cardiovascular Disease or Complications thereof
#5122Methods for detecting pre-diabetes and diabetes
#5123Diagnostic method for Alzheimer's disease
#5124COMPOSITION, KIT AND METHOD FOR ASSAYING NEUROPATHY
#5125Molecular diagnosis and classification of malignant melanoma
#5126Agonistic binding molecules to the human OX40 receptor
#5127PANCREATIC BETA-CELL MASS BIOMARKER
#5128Tumor specific antibodies and uses therefor
#5129Biomarkers for insulin sensitizer drug response
#5130USE OF PROCALCITONIN (PCT) IN PROGNOSIS FOLLOWING ACUTE CORONARY SYNDROMES
#5131METHOD FOR DETECTING THE EXISTENCE OF RENAL CALCULI AND/OR INFLAMMATION OF THE EXCRETORY URINARY TRACTS
#5132DIAGNOSIS OF HEREDITARY SPASTIC PARAPLEGIAS (HSP) BY IDENTIFICATION OF A MUTATION IN THE ZFYVE26 GENE OR PROTEIN
#5133MEANS AND METHODS DIAGNOSING GASTRIC BYPASS AND CONDITIONS RELATED THERETO
#5134Peptide biosynthesis and pain therapy
#5135Peptide biosynthesis and pain therapy
#5136THERAPEUTIC AGENTS AND TARGETS
#5137Methods of predicting and treating adverse cardiac events
#5138MULTIMARKER PANEL FOR DIFFERENTIATION OF DILATED CARDIOMYOPATHY AND AS A BASIS FOR DIFFERENTIAL THERAPY
#5139PRO-ENDOTHELIN-1 FOR THE PREDICTION OF IMPAIRED PEAK OXYGEN CONSUMPTION
#5140PRO-ENDOTHELIN-1 LEVELS FOR THE PREDICTION OF RISK OF TACHYARRHYTMIC EVENTS
#5141Highly sensitive system and method for analysis of troponin
#5142Elevation of Induced Heat Shock Proteins in Patient's Cerebral Spinal Fluid: A Biomarker of Risk/Onset of Ischemia and/or Paralysis in Aortic Surgery
#5143Biomarkers For Prognosis of Pulmonary Diseases
#5144DIAGNOSTIC METHOD FOR PEANUT ALLERGY
#5145METHOD FOR DIAGNOSING LIVER FIBROSIS
#5146Novel genes and markers in type 2 diabetes and obesity
#5147Novel genes and markers in type 2 diabetes and obesity
#5148CTGF AS A BIOMARKER, THERAPEUTIC AND DIAGNOSTIC TARGET
#5149Resistin as a Marker and Therapeutic Target for Cardiovascular Disease
#5150Primitive vascular progenitor cells and uses thereof
#5151DIAGNOSTIC OF PRE-SYMPTOMATIC METABOLIC SYNDROME
#5152DIAGNOSIS OF SEPSIS
#5153DIAGNOSIS OF EARLY STAGE CARDIAC DYSFUNCTION
#5154Methods and compositions for monitoring and risk prediction in cardiorenal syndrome
#5155Biomarkers
#5156Method for identifying a subject at risk of developing heart failure by determining the level of galectin-3 or thrombospondin-2
#5157Methods for diagnosis, prognosis and methods of treatment
#5158Methods and products for diagnosing autoimmune disease and gastric cancer linked with atrophic gastritis
#5159MOLECULAR SIGNATURE FOR FIBROSIS AND ATROPHY
#5160MARKERS FOR DETERMINING DNA DAMAGE AND TELOMERE DYSFUNCTION FOR THE DETERMINATION OF THE BIOLOGICAL AGE, REGENERATIVE CAPACITY, CANCER RISK, THE RISK OF DEVELOPING AGE-RELATED DISEASES AND THE PROGNOSIS OF CHRONIC DISEASES IN HUMANS AND ANIMALS
#5161Compositions and methods for the identification, assessment, prevention and therapy of human cancers
#5162Compositions and Methods for Diagnosing and Treating Insulin Resistance
#5163T cell receptors and related materials and methods of use
#5164COMPOSITIONS AND METHODS FOR REDUCING THE LIKELIHOOD OF PREECLAMPSIA IN RECIPIENTS OF ARTIFICIAL INSEMINATION
#5165COMPOSITIONS AND METHODS FOR REDUCING THE LIKELIHOOD OF PRETERM LABOR IN RECIPIENTS OF ARTIFICIAL INSEMINATION
#5166Prophylactic/therapeutic agents for lifestyle-related diseases
#5167METHODS AND KITS FOR REDUCING THE LIKELIHOOD OF IMPLANTATION FAILURE AND PREGNANCY-RELATED DISORDERS IN RECIPIENTS OF ARTIFICIAL INSEMINATION
#5168POULTRY VIRAL MATERIALS AND METHODS RELATED THERETO
#5169THERAPEUTIC AND DIAGNOSTIC AGENTS
#5170COMPOSITIONS AND METHODS FOR TREATING CANCER AND MODULATING STRESS GRANULE FORMATION
#5171Thioredoxin interacting protein (TXNIP) as regulator of vascular function
#5172COMPOSITIONS AND METHODS FOR REDUCING THE LIKELIHOOD OF SPONTANEOUS ABORTION IN RECIPIENTS OF ARTIFICAL INSEMINATION
#5173Isolated antibodies against biologically active leptin-related peptides
#5174IgA nephropathy testing method and test kit
#5175DRUG SAFETY TEST USING PENTRAXIN-3 (PTX-3)
#5176High molecular weight Ngal as a biomarker for chronic kidney disease
#5177ATTRACTIN/MAHOGANY-LIKE POLYPEPTIDES, POLYNUCLEOTIDES, ANTIBODIES AND METHODS OF USE THEREOF
#5178Biomarkers for the diagnosis of ALS
#5179BIOMARKERS ASSOCIATED WITH NEPHROPATHY
#5180URINE AND SERUM BIOMARKERS ASSOCIATED WITH DIABETIC NEPHROPATHY
#5181Sclerostin and the inhibition of WNT signaling and bone formation
#5182MEANS AND METHODS FOR DETERMINING THE ARTERIOSCLEROTIC STENOSIS USING INFLAMMATORY BIOMARKERS
#5183VASCULAR MARKERS IN THE REMODELING OF CARDIAC INJURY
#5184Biomarkers associated with nephropathy
#5185BIOMARKERS ASSOCIATED WITH NEPHROPATHY
#5186DIAGNOSIS, STAGING AND MONITORING OF INFLAMMATORY BOWEL DISEASE
#5187Peripheral-type benzodiazepine receptor expression level as an index of organ damage and regeneration
#5188Methods of distinguishing between glutamine formed by cataplerosis or proteolysis
#5189Urine and serum biomarkers associated with diabetic nephropathy
#5190Cartilage intermediate layer protein 2 C1 and its use to differentiate osteoarthritis from rheumatoid arthritis and non-disease conditions
#5191RECOMBINANT 12-KDA PROTEIN USEFUL FOR THE DETECTION OF RESPIRATORY ALLERGIES
#5192CARDIOVASCULAR SAFETY ASSAY
#5193Detection of cardiac markers on a droplet actuator
#5194Methods of identifying anti-inflammatory compounds
#5195Galectin-3 and cardiac resynchronization therapy
#5196Antibodies that recognize cutting edge within the TGF-β activation controlling region
#5197CLASSIFICATION OF INDIVIDUALS SUFFERING FROM CARDIOVASCULAR DISEASES ACCORDING TO SURVIVAL PROGNOSES AS FOUND BY MEASURING THE LEVELS OF BIOMARKER YKL-40
#5198Methods for Diagnosing and Treating Iron Dysregulation
#5199Uses of Lp-PLA2 in combination to assess coronary risk
#5200CHEMICAL MODULATION OF ELECTRONIC AND MAGNETIC PROPERTIES OF GRAPHENE
#5201Antibody against RGD in amino acid sequence of extracellular matrix protein and production method and use of the same
#5202Methods and kits for the diagnosis of rheumatoid arthritis
#5203Devices for Detecting Renal Disorders
#5204Methods and Devices for Detecting Kidney Damage
#5205Methods and Devices for Detecting Diabetic Nephropathy and Associated Disorders
#5206Computer Methods and Devices for Detecting Kidney Damage
#5207Use of B-Type Natriuretic Peptide as a Prognostic Indicator in Acute Coronary Syndromes
#5208Thrombospondin Fragments and Uses Thereof in Clinical Assays for Cancer and Generation of Antibodies and Other Binding Agents
#5209Assessing susceptibility to cardiac intervention, susceptibility to therapy for heart failure, risk of mortality or further cardiovascular events, and risk of subsequent pulmonary embolism in relevant patients based on determinations of GDF-15, natriuretic peptide, cardiac troponin or combinations thereof
#5210Atherosclerosis marker and use thereof
#5211Methods and devices for detecting obstructive uropathy and associated disorders
#5212Methods and Devices for Detecting Glomerulonephritis and Associated Disorders
#5213REAL-TIME ASSAYS OF NEURO-HUMORAL FACTORS TO ASSESS CARDIOVASCULAR STRESS
#5214METHODS AND COMPOSITIONS FOR DIAGNOSTIC USE IN CANCER PATIENTS
#5215Biomarker for diagnosis, prediction and/or prognosis of sepsis and uses thereof
#5216Markers of acute kidney failure
#5217Minimally invasive assessment of IgE mediated allergy
#5218L-FABP, natriuretic peptides, and cardiac troponins in subjects in need of cardiac therapy
#5219METHOD FOR ESTIMATING RISK OF ACUTE KIDNEY INJURY
#5220Protein Markers for Cardiovascular Events
#5221Vm23 and Vm24, two scorpion peptides that block human T-lymphocyte potassium channels (sub-type Kv1.3) with high selectivity and decrease the in vivo DTH-responses in rats
#5222Keratin 8 mutations are risk factors for developing liver disease of multiple etiologies
#5223Methods for the diagnosis, risk assessment, and monitoring of autism spectrum disorders
#5224METHOD FOR RISK REDUCTION IN GLYCEMIC CONTROL
#5225Biomarkers for prediction of major adverse cardiac events and uses thereof
#5226GENE SIGNATURES
#5227CACNB2 nucleic acid mutations as indicators of shorter than normal QT interval and ST segment elevation associated with sudden cardiac death
#5228Assay for soluble CD200
#522914-3-3 eta antibodies and uses thereof for the diagnosis and treatment of arthritis
#5230Methods useful for vitamin D deficiency and related disorders
#5231METHOD FOR TESTING A SUBJECT THOUGHT TO HAVE OR TO BE PREDISPOSED TO ASTHMA
#5232ASSESSING CONGESTIVE HEART RISK IN PATIENTS TREATED OR POTENTIALLY TO BE TREATED WITH A PEROXISOME-PROLIFERATOR-ACTIVATOR-RECEPTOR-GAMMA AGONIST OR A THIAZOLIDINEDIONE
#5233Method of promoting apoptosis of differentiated adipocytes and increasing endogenous expression of SFRP-5 peptide by administration of SFRP-5 peptide
#5234YKL-40 as a general marker for non-specific disease
#5235METHODS FOR DETECTING MAJOR ADVERSE CARDIOVASCULAR AND CEREBROVASCULAR EVENTS
#5236Method For Determining The Type of an Inflammatory-Rheumatic Disease in Synovial Fluid
#5237FSTL-1 as a biomaker of inflammation
#5238Method for determining the risk of crohn's disease-related complications
#5239NELL-1 ENHANCED BONE MINERALIZATION
#5240SUSCEPTIBILITY TO BONE DAMAGE
#5241METHOD FOR DIRECT DETECTION OF ISCHEMIA-MODIFIED ALBUMIN USING A PARTNER FOR BINDING TO AN ALDEHYDE DERIVATIVE RESULTING FROM THE PEROXIDATION OF LIPIDS IN BOUND FORM
#5242Diagnosis and risk stratification using NT-proET-1
#5243METHOD OF DETECTING CALCIFYING NANOPARTICLES AND SUSCEPTIBILITY TO CALCIFYING NANOPARTICLE INFORMATION
#5244METHOD OF IMMUNOLOGICAL ANALYSIS FOR DETECTION OF ANTIBODIES AGAINST HUMAN GSTT1 (ANTI-HGSTT1)
#5245Identifying organ damage
#5246Methods of Reducing the Production of Reactive Oxygen Species and Methods of Screening or Identifying Compounds and Compositions that Reduce the Production of Reactive Oxygen Species
#5247PROGNOSTIC ASSAY FOR DETERMINING T CELL RESPONSE TO HLA ANTIGENS AND USE THEREOF IN FIELD OF TISSUE TRANSPLANTATION
#5248HEMATOPOIETIC CELLS EXPRESSING THE PROTEIN SUSD3 AND LIGANDS FOR THE PROTEIN SUSD3
#5249Diagnosis and treatment for endometriosis
#5250Composition for treatment and improvement of diabetes comprising caveolin as active ingredient and a method for treatment of diabetes using it
#5251METHOD FOR DETECTING INFLAMMATORY DISORDERS OF THE CENTRAL NERVOUS SYSTEM
#5252METHOD AND MARKER FOR DIAGNOSIS OF TUBULAR KIDNEY DAMAGE AND ILLNESS
#5253Use of IMP3 as a prognostic marker for cancer
#5254RISK ANALYSIS IN PATIENTS WITH AND WITHOUT METABOLIC SYNDROME
#5255Method for evaluation or selection of adiponectin secretion regulator
#5256Method for diagnosing pulmonary artery hypertension
#5257USE OF A NITRATED PROTEIN OR PEPTIDE SEQUENCE FOR THE IMPLEMENTATION OF A METHOD OF DIAGNOSIS
#5258Dietary Calcium for Reducing the Production of Reactive Oxygen Species
#5259Genetic variants in a hypertension susceptibility gene Stk39 and uses thereof
#5260Method for detecting disease markers
#5261Detection and treatment of schizophrenia
#5262DETECTION OF ANTI-RIBOSOMAL P PROTEIN ANTIBODIES BY MEANS OF SYNTHETIC PEPTIDES
#5263Endothelial monocyte activation polypeptide II, a biomarker for use in diagnosis and treatment of brain injury
#5264Use of SFRP-3 in the assessment of heart failure
#5265Methods of treating autism spectrum disorders and compositions for same
#5266METHODS, SYSTEMS AND PRODUCTS FOR PREDICTING RESPONSE OF TUMOR CELLS TO A THERAPEUTIC AGENT AND TREATING A PATIENT ACCORDING TO THE PREDICTED RESPONSE
#5267Methods for diagnosing and treating cancers
#526814-3-3 Antagonists for the Prevention and Treatment of Arthritis
#5269TAZ/WWTR1 for diagnosis and treatment of cancer
#5270Methods of Screening for Anti-Angiogenic Compounds
#5271MEANS AND METHODS FOR THE SPECIFIC INHIBITION OF GENES IN CELLS AND TISSUE OF THE CNS AND/OR EYE
#5272Gene defects and mutant ALK kinase in human solid tumors
#5273COMPOSITIONS FOR CONTROLLING HAIR GROWTH
#5274Salivary protein biomarkers for human oral cancer
#5275Oligopeptidic compounds and uses thereof
#5276Contraceptives Based on SP22 and SP22 Antibodies
#5277GRAM-POSITIVE BACTERIA SPECIFIC BINDING COMPOUNDS
#5278TLE3 as a marker for chemotherapy
#5279Methods and apparatus for the detection and differentiation of non-sialated proteins from sialated proteins in a fluid sample
#5280SOLUBLE FAS IN ACUTE CORONARY SYNDROMES DIAGNOSIS
#5281METHOD FOR DIAGNOSING ACUTE CORONARY SYNDROME
#5282Methods for improving the recovery of troponin I and T in membranes, filters and vessels
#5283METHODS FOR MEASURING THE INSULIN RECEPTOR ALPHA SUBUNIT
#5284COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING NEUROPSYCHIATRIC DISORDERS
#5285Methods for producing an immune response to tuberculosis
#5286Methods for treating chronic pelvic pain syndrome with antibodies that binds MCP-1 or MIP-1A
#5287METHODS OF TREATING PRE-ECLAMPSIA OR ECLAMPSIA
#5288MCAM modulation and uses thereof
#5289Predicting atrial fibrillation recurrence by protease and protease inhibitor profiling
#5290Methods to increase or decrease bone density
#5291Methods of diagnosing non-alcoholic steatohepatitis (NASH)
#5292DIAGNOSTIC METHOD FOR DISORDERS USING COPEPTIN
#5293DIAGNOSTIC METHOD OF MUCOPOLYSACCHARIDOSES
#5294Biomarkers
#5295Markers associated with arteriovascular events and methods of use thereof
#5296PHENOTYPIC RATIO OF SERUM AMYLOID IN PRE- AND TYPE 2 DIABETES
#5297Cystic fibrosis transmembrane conductance regulator gene mutations
#5298Reagents and methods for use in cancer diagnosis, classification and therapy
#5299BIOMARKERS FOR THE PREDICTION OF RENAL INJURY
#5300Highly sensitive biomarker panels
#5301Method and kit for detection of autoimmune chronic urticaria
#5302HEMATOPOIETIC CELLS EXPRESSING THE PROTEIN KRTCAP3 AND LIGANDS FOR THE PROTEIN KRTCAP3
#5303Compositions and methods for treating and preventing heart tissue degeneration and uses thereof
#5304Isolated antibodies against biologically active leptin-related peptides
#5305Methods of screening for a compound that reduces atherogenesis
#5306Early detection of diabetes
#5307Methods and compositions for diagnosing osteoarthritis in a feline
#5308SLEEP APNEA
#5309Biochemical markers for CVD risk assessment
#5310Serum Biomarkers for Diagnosing Liver Fibrosis and Method for Measuring the Same
#5311Methods for identifying analgesic agents
#5312Humanized FcγRIIB-specific antibodies and methods of use thereof
#5313CHARACTERIZATION OF IL-17F AND IL-17R INTERACTIONS
#5314Diagnosis of liver pathology through assesment of protein glycosylation
#5315Biomarkers of Hemorrhagic Shock
#5316Granzyme A and granzyme B diagnostics
#5317Diagnostic method for celiac sprue
#5318BIOCHEMICAL MARKERS FOR CVD RISK ASSESSMENT
#5319METHODS OF DIAGNOSING TISSUE FIBROSIS
#5320DIAGNOSTIC TEST
#5321Method for Identifying Mammals at Risk for Elevated intracranial Pressure
#5322METHOD FOR DIAGNOSIS OF INFLAMMATORY DISEASES USING CALGRANULIN C
#5323Cosmetic use of a protein belonging to the ribonuclease family
#5324METABOLIC FUEL SWITCHING BIOMARKER
#5325Compositions and methods for detecting juvenile renal dysplasia or calcium oxalate stones in dogs
#5326METHODS OF SCREENING FOR COMPOUNDS THAT MODULATE TAFIA ACTIVITY, COMPOUNDS, AND METHODS OF USING THE COMPOUNDS
#5327Use of 2 anti-SPARC antibodies to predict response to melanoma chemotherapy
#5328SCREENING, THERAPY AND DIAGNOSIS
#5329Method of use of fibroblast growth factor, vascular endothelial growth factor and related proteins in the treatment of acute and chronic heart disease
#5330Conditionally Active Ribozymes And Uses Thereof
#5331Diagnostic method
#5332Biomarkers for sepsis
#5333Diagnostic and therapeutic tools for diseases altering vascular function
#5334DIAGNOSTIC USE OF INDIVIDUAL MOLECULAR FORMS OF A BIOMARKER
#5335Methods for determining the risk of prenatal complications
#5336Gene defects and mutant ALK kinase in human solid tumors
#5337Method and apparatus for diagnosing age-related macular degeneration
#5338Soluble GP130 muteins with improved binding activity
#5339Biomarkers for liver injury
#5340Diagnostic methods for acute ischemic disease using activated hepcidin as an indicator
#5341METHOD OF DIAGNOSTIC RHEUMATOID ARTHRITIS BY SUGAR CHAIN ANALYSIS
#5342Identification and quantification of biomarkers for evaluating the risk of preterm birth
#5343Highly sensitive system and methods for analysis of troponin
#5344CC2D2A gene mutations associated with Joubert syndrome and diagnostic methods for identifying the same
#5345Upregulation of RACK-1 in melanoma and its use as a marker
#5346Methods and compositions for the treatment of proteinuric diseases
#5347Prognosis and therapy of liver failure
#5348T cell receptor having binding affinity for a peptide-MHC complex and uses thereof
#5349PROTEIN PROFILE FOR OSTEOARTHRITIS
#5350BIOMARKERS AND METHODS FOR DIAGNOSING, PREDICTING AND/OR PROGNOSING SEPSIS AND USES THEREOF
#5351Clinical diagnosis of hepatic fibrosis using a novel panel of low abundant human plasma protein biomarkers
#5352ErbB Surface Receptor Complexes as Biomarkers
#5353Biomarker for diagnosing heart disease and the use thereof
#5354BIOMARKERS FOR TRICHOGENICITY
#5355Genes and polypeptides relating to hepatocellular or colorectal carcinoma
#5356Systems and methods for diagnosis and monitoring of bacteria-related conditions
#5357METHOD FOR IDENTIFYING A RENAL FIBROSIS PROCESS USE OF SNAIL- ACTIVITY-INHIBITING COMPOUNDS IN THE PRODUCTION OF PHARMACEUTICAL COMPOSITIONS, METHOD FOR IDENTIFYING SAID INHIBITING COMPOUNDS, SAID PHARMACEUTICAL COMPOSITIONS AND APPLICATIONS THEREOF
#5358Trimethylamine compounds as risk predictors of cardiovascular disease
#5359Marker for inflammatory conditions
#5360Methods for detecting pre-diabetes and diabetes using differential protein glycosylation
#5361Methods and devices for the detection of biofilm
#5362USE OF IGFBP-7 IN THE ASSESSMENT OF HEART FAILURE
#5363Methods for Detecting Metabolic States by Laser Ablation Electrospray Ionization Mass Spectrometry
#5364COMPOSITION FOR IMPROVING LIVER METABOLISM AND DIAGNOSTIC METHOD
#5365Diagnosis of mood disorders by detecting latent infection with human herpesvirus-6
#5366METHODS AND KITS FOR DIAGNOSIS AND TREATMENT OF CELL-CELL JUNCTION RELATED DISORDERS
#5367Biomarkers For Fatty Liver Disease And Methods Using The Same
#5368USE OF BNP-TYPE PEPTIDES FOR PREDICTING DIALYSIS NEED
#5369USE OF MODIFIED EXTRACELLULAR MATRIX PROTEINS IN DIAGNOSIS AND TREATMENT OF ATHEROSCLEROSIS
#5370diagnostics and screening methods
#5371Mammalian receptor proteins DCRS5; method of treatment
#5372WIRELESS MONITORING BIO-DIAGNOSIS SYSTEM
#5373PEPTIDE COMPOUNDS FOR TREATING REFRACTORY STATUS EPILEPTICUS
#5374Methods and Kits for Predicting Treatment Response in Type II Diabetes Mellitus Patients
#5375DIAGNOSIS OF ABDOMINAL AORTIC ANEURYSM USING BIOMARKERS
#5376Methods for Diagnosis of Sepsis and Risk of Death
#5377Genetic markers associated with endometriosis and use thereof
#5378Structure of the insulin receptor ectodomain
#5379METHOD FOR DETECTION OF A DISEASE-SPECIFIC COMBINATORIAL MOLECULAR PATTERN MOTIF IN A TISSUE SAMPLE OF A PATIENT'S SKIN
#5380Detecting phospholipidosis and diagnosing lysosomal storage disorders
#5381IMMUNODEFICIENCY SCREENING AT POINT OF CARE
#5382Monocyte-derived nucleic acids and related compositions and methods
#5383METHOD OF TREATING CACHEXIA WITH THE REMOVAL OR INACTIVATION OF MACROPHAGE INHIBITORY CYTOKINE-1
#5384CONDENSED PYRIDINE DERIVATIVE AND USE THEREOF
#5385USING GDF 15 TO ASSESS PATIENTS PRESENTING TO EMERGENCY UNITS
#5386Method of evaluating IGT, IGT-evaluating apparatus, IGT-evaluating method, IGT--evaluating system, IGT-evaluating program, recording medium, and method of searching for prophylactic/ameliorating substance for IGT
#5387Biomarkers for liver diseases and method for using the same
#5388Methods and kits for screening transplant recipients and candidates
#5389Method for diagnosing the metabolic syndrome (MS)
#5390Use of tetrahydrobiopterin as a marker and a therapeutic agent for fabry disease
#5391Anti aging agents and methods to identify them
#5392ANALYSIS APPARATUS AND ANALYSIS METHOD FOR CAPILLARY ELECTROPHORESIS
#5393Biomarkers for Atherosclerosis
#5394NOVEL AS160-LIKE PROTEIN, TEST SYSTEMS, METHODS AND USES INVOLVING IT FOR THE IDENTIFICATION OF DIABETES TYPE 2 THERAPEUTICS
#5395NT-proBNP/troponin ratio for assessing myocardial dysfunction
#5396Natriuretic peptides for diagnosing cardiac complications due to coronary catheterization
#5397Method for assessing risk of heart failure
#5398USE OF BIOMARKERS FOR ASSESSING TREATMENT OF GASTROINTESTINAL INFLAMMATORY DISORDERS WITH BETA7 INTEGRIN ANTAGONISTS
#5399ADAMTS4 as a blood biomarker and therapeutic target for chronic renal failure
#5400NGAL for reduction and amelioration of ischemic and nephrotoxic injuries